Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Healthcare Triangle ( (HCTI) ) is now available.
On January 22, 2026, Healthcare Triangle entered into a Share Purchase Agreement via its subsidiary Teyame AI Holdings to acquire all equity interests in Spain-based Teyamé 360 S.L. and Datono Mediación S.L., leaders in AI-powered omnichannel customer experience solutions, with the transaction closing on January 29, 2026 and deemed effective as of January 1, 2026. The deal values the acquired companies at up to $50 million in a mix of staged cash payments, restricted common stock, non-voting convertible preferred stock, and a performance-based earnout in preferred shares for key managers, while incorporating price-adjustment mechanisms, shareholder-approval conditions on conversion, and structural limits on common share issuance. According to financial information from Teyame, the acquired assets generated about $32 million in incremental revenue and $3.6 million in EBITDA for 2025 and are projected to add $38 million in next-twelve-month revenue and $5 million in EBITDA, marking a strategic pivot for Healthcare Triangle toward AI-driven, global SaaS patient and customer engagement, with an expanded footprint in Europe and Latin America and a deeper integration of Agentic Generative AI into its healthcare technology stack.
The most recent analyst rating on (HCTI) stock is a Hold with a $0.28 price target. To see the full list of analyst forecasts on Healthcare Triangle stock, see the HCTI Stock Forecast page.
Spark’s Take on HCTI Stock
According to Spark, TipRanks’ AI Analyst, HCTI is a Underperform.
The score is held down primarily by very weak financial performance (persistent losses, margin compression, and heavy cash burn) and strongly bearish technicals (well below key moving averages with negative momentum). Corporate events provide some strategic upside via the AI asset acquisition, but the accompanying financing actions increase dilution risk, while valuation offers limited support due to negative earnings and no dividend yield data.
To see Spark’s full report on HCTI stock, click here.
More about Healthcare Triangle
Healthcare Triangle, Inc., based in Pleasanton, California, is a digital transformation solutions provider focused on healthcare and life sciences, serving hospitals and health systems, payers, and pharma/life sciences organizations. The company offers cloud, data, security and compliance, interoperability, and performance optimization services through platforms such as its HITRUST-certified CloudEz and DataEz (CaDP), helping heavily regulated healthcare clients adopt new technologies, manage data lifecycles, and enhance clinical and business outcomes.
Average Trading Volume: 5,557,354
Technical Sentiment Signal: Sell
Current Market Cap: $3.12M
For an in-depth examination of HCTI stock, go to TipRanks’ Overview page.